EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

A Clinically Practical Nomogram for Predicting Survival in Elderly Patients (≥ 65 Years) With Bladder Urothelial Carcinoma: A Study Based on SEER Database and External Validation

Jufang Wei iD, Chunmeng Wei iD, Juan Chen iD, Xianhui Zhang iD, Wenpiao Zhao iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70418 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cancer Reports, 2025. Verfasst von Jufang Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xiangsihu Community Health Service Center, Xiangsihu Community Health Service Center, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, Ch…. Hauptthemen laut MEDLINE: Nomograms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bladder urothelial carcinoma is a common malignancy in the elderly, yet accurate prognostic tools for older patients remain limited.

Aims

This research aimed to create and validate nomogram predicting overall survival (OS) for elderly patients aged 65 years and older with urothelial carcinoma of the bladder (UCB).

Methods

We sourced 12702 UCB patients diagnosed between 2004 and 2015 from the Surveillance, Epidemiology, and End Results database. The patients were randomized into training (70%) and internal validation (30%) cohorts. In addition, 55 patients from Minzu Hospital of Guangxi Zhuang Autonomous Region between 2012 and 2022 were selected as the external validation cohort. Utilizing univariate and multivariate Cox regression analyses, we devised a nomogram forecasting 1‐, 3‐, and 5‐year OS. Several metrics, including the consistency index (C‐index), calibration plots, area under the receiver operator characteristics (ROC) curve, and decision curve analysis (DCA) were used to validate the validity and clinical utility of the nomogram. Patients were categorized into high‐ and low‐risk profiles, and their survival outcomes were contrasted using the Kaplan‐Meier method and the log‐rank test.

Results

Age, race, marriage, AJCC stage, tumor size, surgery, radiotherapy, and chemotherapy were identified as independent prognostic factors of OS. In the training cohort, internal validation cohort and external validation cohort, the nomogram for predicting OS achieved C‐index values of 0.673 (95% CI: 0.665−0.681), 0.672 (95% CI: 0.660−0.684), and 0.826 (95% CI: 0.732−0.920), respectively. In all cohorts, the calibration plots revealed high consistency between actual and predicted values. The nomogram depicted by ROC and DCA showcased superior stability, predictive value, and clinical applicability for 1, 3−, and 5‐year OS. The risk stratification delineated patients into low‐ and high‐risk brackets, revealing significant prognostic distinctions ( p ⟨ 0.05).

Conclusions

Based on the SEER database and Chinese data, we developed a reliable nomogram forecasting 1‐, 3‐, and 5‐year OS for older patients with UCB. The nomogram can identified high‐risk and low‐risk patients, aiding clinicians in personalised treatment and prognostic evaluations. This allows high‐risk patients to receive intensive treatment or close follow‐up, while low‐risk patients can avoid overtreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsUrinary Bladder NeoplasmsCarcinoma, Transitional CellHumansMaleSEER ProgramFemaleAgedPrognosisAged, 80 and overSurvival RateRisk AssessmentChina

Stichwörter der Autor:innen

older patientsoverall survivalprognosis nomogramsurveillance, epidemiology, and end resultsurothelial carcinoma of the bladder

Autor:innen und Institutionen

  • Xiangsihu Community Health Service Center, Xiangsihu Community Health Service Center, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Guangxi Medical University Affiliated Ethnic Hospital, Nanning, China.
  • Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nann…
  • Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Department of Gastroenterology, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

ORCID-Profile: Jufang Wei, Chunmeng Wei, Juan Chen, Xianhui Zhang, Wenpiao Zhao

Zitieren

APA

Wei, J., Wei, C., Chen, J., Zhang, X., & Zhao, W. (2025). A Clinically Practical Nomogram for Predicting Survival in Elderly Patients (≥ 65 Years) With Bladder Urothelial Carcinoma: A Study Based on SEER Database and External Validation. Cancer Reports. https://doi.org/10.1002/cnr2.70418

Vancouver

Wei J, Wei C, Chen J, Zhang X, Zhao W. A Clinically Practical Nomogram for Predicting Survival in Elderly Patients (≥ 65 Years) With Bladder Urothelial Carcinoma: A Study Based on SEER Database and External Validation. Cancer Reports. 2025. doi:10.1002/cnr2.70418

BibTeX
@article{Wei2025,
  author = {Wei, Jufang and Wei, Chunmeng and Chen, Juan and Zhang, Xianhui and Zhao, Wenpiao},
  title = {A Clinically Practical Nomogram for Predicting Survival in Elderly Patients (≥ 65 Years) With Bladder Urothelial Carcinoma: A Study Based on SEER Database and External Validation},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70418}
}
Kostenlos starten →